BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 35446403)

  • 1. Rational guide RNA engineering for small-molecule control of CRISPR/Cas9 and gene editing.
    Liu X; Xiong W; Qi Q; Zhang Y; Ji H; Cui S; An J; Sun X; Yin H; Tian T; Zhou X
    Nucleic Acids Res; 2022 May; 50(8):4769-4783. PubMed ID: 35446403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
    Kumar R; Tiwari K; Saudagar P
    Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of an Inducible CRISPR/Cas9 System for CXCR4 Gene and Demonstration of its Effects on MKN-45 Cells.
    Peng Y; Yang T; Tang X; Chen F; Wang S
    Cell Biochem Biophys; 2020 Mar; 78(1):23-30. PubMed ID: 31875277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
    Basila M; Kelley ML; Smith AVB
    PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EasyGuide Plasmids Support in Vivo Assembly of gRNAs for CRISPR/Cas9 Applications in
    Jacobus AP; Barreto JA; de Bem LS; Menegon YA; Fier Í; Bueno JGR; Dos Santos LV; Gross J
    ACS Synth Biol; 2022 Nov; 11(11):3886-3891. PubMed ID: 36257021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage.
    Riesenberg S; Helmbrecht N; Kanis P; Maricic T; Pääbo S
    Nat Commun; 2022 Jan; 13(1):489. PubMed ID: 35078986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed Simian Immunodeficiency Virus-Specific Paired RNA-Guided Cas9 Nickases Inactivate Proviral DNA.
    Smith LM; Ladner JT; Hodara VL; Parodi LM; Harris RA; Callery JE; Lai Z; Zou Y; Raveedran M; Rogers J; Giavedoni LD
    J Virol; 2021 Nov; 95(23):e0088221. PubMed ID: 34549979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.
    Zhu LJ; Holmes BR; Aronin N; Brodsky MH
    PLoS One; 2014; 9(9):e108424. PubMed ID: 25247697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multiplexed CRISPR/Cas9 Editing System Based on the Endogenous tRNA Processing.
    Xie K; Yang Y
    Methods Mol Biol; 2019; 1917():63-73. PubMed ID: 30610628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frankenstein Cas9: engineering improved gene editing systems.
    Vos PD; Filipovska A; Rackham O
    Biochem Soc Trans; 2022 Oct; 50(5):1505-1516. PubMed ID: 36305591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-step genome editing of porcine zygotes through the electroporation of a CRISPR/Cas9 system with two guide RNAs.
    Hirata M; Wittayarat M; Tanihara F; Sato Y; Namula Z; Le QA; Lin Q; Takebayashi K; Otoi T
    In Vitro Cell Dev Biol Anim; 2020 Sep; 56(8):614-621. PubMed ID: 32978715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control.
    Brown W; Zhou W; Deiters A
    Chembiochem; 2021 Jan; 22(1):63-72. PubMed ID: 32833316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and Efficient Gene Deletion by CRISPR/Cas9.
    Neldeborg S; Lin L; Stougaard M; Luo Y
    Methods Mol Biol; 2019; 1961():233-247. PubMed ID: 30912049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Engineered CRISPR-Cas-Mediated Systems for Site-Specific RNA Editing.
    Marina RJ; Brannan KW; Dong KD; Yee BA; Yeo GW
    Cell Rep; 2020 Nov; 33(5):108350. PubMed ID: 33147453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Prediction of CRISPR/Cas9 Target Sites Reveals Potential Off-Target Risks in Human and Mouse.
    Wang Q; Ui-Tei K
    Methods Mol Biol; 2017; 1630():43-53. PubMed ID: 28643248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cas9-mediated DNA cleavage guided by enzymatically prepared 4'-thio-modified RNA.
    Saito-Tarashima N; Ueno M; Murai A; Matsuo A; Minakawa N
    Org Biomol Chem; 2022 Jul; 20(26):5245-5248. PubMed ID: 35726625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems.
    Briner AE; Barrangou R
    Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The length of guide RNA and target DNA heteroduplex effects on CRISPR/Cas9 mediated genome editing efficiency in porcine cells.
    Lv J; Wu S; Wei R; Li Y; Jin J; Mu Y; Zhang Y; Kong Q; Weng X; Liu Z
    J Vet Sci; 2019 May; 20(3):e23. PubMed ID: 31161741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
    Haeussler M; Concordet JP
    J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.